Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Managing Design Changes and Documentation

Posted on By

SOP for Managing Design Changes and Documentation

Comprehensive Guide to Managing Design Changes and Documentation for Medical Devices

1) Purpose

The purpose of this SOP is to define a structured process for managing design changes and associated documentation for medical devices. Proper management ensures that design modifications are systematically evaluated, implemented, and documented to maintain compliance and product quality.

2) Scope

This SOP applies to all design changes made to medical devices during development, manufacturing, or post-market phases. It is relevant to product development, quality assurance, regulatory affairs, and document control teams.

3) Responsibilities

– Product Development Team: Proposes and implements design changes and ensures technical feasibility.
– Quality Assurance (QA): Reviews and approves design changes for compliance with quality standards.
– Regulatory Affairs: Ensures that design changes comply with regulatory requirements and are updated in submissions if needed.
– Risk Management Team: Assesses the impact of changes on safety and risk management plans.
– Document Control Team: Maintains records of design changes and ensures proper version control.

4) Procedure

4.1 Initiating Design Changes
4.1.1 Identifying the Need for Change
– Identify design changes due to:
– Feedback from testing or clinical evaluations.
– Regulatory updates or compliance requirements.
– Post-market surveillance findings

(e.g., adverse events or customer complaints).
– Process improvements or cost optimizations.

See also  SOP for User Needs and Requirement Specification

4.1.2 Documenting Change Requests
– Complete a Design Change Request (DCR) form, including:
– Description of the proposed change.
– Justification and objectives.
– Impact assessment on device functionality, safety, and compliance.
– Submit the DCR to the change control board (CCB) for review.

4.2 Evaluating Design Changes
4.2.1 Risk Assessment
– Assess risks associated with the proposed change, focusing on:
– Potential impact on patient safety and device performance.
– Changes to manufacturing processes or materials.
– New hazards introduced by the change.
– Update the risk management file with findings.

4.2.2 Regulatory Impact Analysis
– Determine whether the change affects regulatory submissions or certifications, such as:
– FDA 510(k) or PMA applications.
– EU MDR technical documentation.
– ISO 13485 quality management system compliance.

4.2.3 Approval Process
– Review the DCR with a cross-functional team, including QA, regulatory affairs, and product development.
– Approve or reject the change based on feasibility, risks, and compliance requirements.
– Record decisions in the Design Change Approval Log.

4.3 Implementing Design Changes
4.3.1 Updating Design Outputs
– Modify design outputs, such as:
– Technical drawings and specifications.
– Bill of materials (BOM).
– Manufacturing and assembly instructions.
– Validate changes through testing and verification to ensure compliance with design inputs.

See also  SOP for Documenting Packaging Material Approvals

4.3.2 Communication and Training
– Communicate approved changes to all relevant teams, including manufacturing, QA, and customer support.
– Conduct training sessions if changes impact production processes or device use.

4.4 Verifying and Validating Design Changes
4.4.1 Verification
– Verify that updated design outputs meet the revised design inputs.
– Perform tests, including:
– Functional performance testing.
– Environmental and durability testing.
– Usability assessments for user-facing changes.

4.4.2 Validation
– Validate that the design change meets user needs and intended use through:
– Clinical evaluations, if applicable.
– Simulated use testing.
– Record validation results in the Design Change Validation Report.

4.5 Documenting Design Changes
4.5.1 Traceability
– Update the traceability matrix to link the design change to relevant inputs, outputs, and test results.

4.5.2 Version Control
– Assign a new version number to the updated design documentation.
– Archive previous versions with proper annotations for traceability.

4.5.3 Updating Regulatory Submissions
– Submit updated design documentation to regulatory authorities, if required.
– Record submission details in the Regulatory Submission Log.

4.6 Monitoring and Continuous Improvement
4.6.1 Post-Implementation Review
– Monitor the impact of the design change through:
– Post-market surveillance.
– Customer feedback.
– Internal audits.
– Use findings to refine the design change process.

See also  SOP for Conducting Internal Quality Audits

4.6.2 Lessons Learned
– Document lessons learned from the design change process to improve future change management activities.

5) Abbreviations

– DCR: Design Change Request
– CCB: Change Control Board
– QA: Quality Assurance
– FDA: Food and Drug Administration
– EU MDR: European Medical Device Regulation
– BOM: Bill of Materials
– SOP: Standard Operating Procedure

6) Documents

– Design Change Request Form
– Risk Management File
– Design Change Approval Log
– Design Change Validation Report
– Traceability Matrix
– Regulatory Submission Log

7) Reference

– FDA CFR Title 21, Part 820: Design Controls
– ISO 13485: Medical Devices – Quality Management Systems
– ISO 14971: Application of Risk Management to Medical Devices
– EU MDR (Regulation (EU) 2017/745): General Safety and Performance Requirements

8) SOP Version

– Version: 1.0
– Effective Date: DD/MM/YYYY
– Approved by: [Name/Title]

Annexure

Annexure 1: Design Change Approval Log Template

Date Change ID Description Approved By Remarks
DD/MM/YYYY DC-001 Update to handle design for improved ergonomics QA Manager Approved for validation

Annexure 2: Design Change Validation Report Template

Date Change ID Test Conducted Results Remarks
DD/MM/YYYY DC-001 Functional Performance Testing Pass Handles meet ergonomic standards
Medical Devices Tags:FDA Medical device SOP requirements, GMP SOP for medical devices, ISO 13485 SOP for Medical device, Medical device compliance SOP, Medical device packaging SOP template, Medical device post-market surveillance SOP, Medical device quality control SOP, Medical device quality SOP, Medical device regulatory SOP, Medical device SOP, SOP for change control in medical device, SOP for device design control, SOP for equipment calibration in medical devices, SOP for handling complaints in medical devices, SOP for manufacturing medical devices, SOP for medical device audits, SOP for medical device inspection, SOP for medical device labeling, SOP for medical device manufacturing, SOP for medical device packaging inspection, SOP for Medical device raw material, SOP for medical device testing, SOP for non-conforming products in medical devices, SOP for packaging medical devices, SOP for product validation, SOP for production planning in medical devices, SOP for risk management in medical devices, SOP for sterilization packaging validation, SOP for sterilization process of Medical device, SOP for traceability in medical device manufacturing

Post navigation

Previous Post: SOP for Documenting Software Development in Medical Devices
Next Post: SOP for Evaluating Supplier Risk in the Supply Chain

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version